Abstract
Herpes simplex keratitis is the most frequent cause of loss of vision from corneal disease in the industrialised world. This has led to the widespread use of a variety of antiviral drugs in treatment and these are reviewed, with particular attention to their clinical value. Study of the reports concerning the use of acyclovir (ACV) in this condition suggests that this antiviral may be more effective than others, not only in acute infections but possibly in herpetic iridocyclitis and also as a prophylactic antiviral cover following corneal grafting.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
